Vector Science and Therapeutics Corp. (TSXV: PAIN)
Health Care · Biotechnology · US
CA$2.80
+16.67% today · +656.8% 1Y
Vector Science and Therapeutics Corp. (TSXV: PAIN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $307.08M.
Over the last twelve months the share price has gained 656.8%, trading between 0.35 and 2.80.
Tweenvest scores Vector Science and Therapeutics Corp. across four factors: quality 74/100. Its strongest factor is quality.
PAIN price history
Key figures
- Market cap
- $307.08M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.18
- Dividend yield
- —
- Beta (5Y)
- 4.76
- 52-week high
- CA$2.80
- 52-week low
- CA$0.35
- Avg volume (3M)
- —
- Shares outstanding
- 156.36M
- Employees
- —
- Next earnings
- —
About Vector Science and Therapeutics Corp.
Vector Science & Therapeutics Corp. engages in the development of novel biomechanical devices and active transdermal drug and peptide delivery platforms. It equips clinicians with non-systemic, localized interventions targeting a broad cross-section of diseases and conditions where systemic delivery of interventions compromises the therapeutic effect or introduces unacceptable harm. The company was founded on April 30, 2021 and is headquartered in Mequon, WI.
- ISIN
- CA92244M1041
- Listed since
- Apr 28, 2026
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Benitec Biopharma Inc.NasdaqCM: BNTC | $317.08M | $9.09 | -4.01% |
| OBI Pharma, Inc.TPEX: 4174 | $312.93M | NT$78.40 | +9.96% |
| Scribe Therapeutics Inc.NasdaqGM: SCTX | $309.82M | $16.36 | -3.71% |
| Galectin Therapeutics Inc.NasdaqCM: GALT | $307.59M | $3.05 | -2.87% |
| Jiangsu Recbio Technology Co., Ltd.SEHK: 2179 | $306.59M | HK$3.90 | 0.00% |
| HJ Science Co., Ltd.SEHK: 6132 | $304.32M | HK$32.44 | -2.99% |
| Kyverna Therapeutics, Inc.NasdaqGS: KYTX | $300.94M | $4.76 | -5.74% |
| Vicore Pharma Holding AB (publ)OM: VICO | $299.86M | Skr10.72 | -2.37% |